Biosimilar Newsletter Archive
-
01.14.21 -- Will These Big Biosimilar Questions Be Answered In 2021?
1/14/2021
01/14/21 Biosimilar Development Newsletter
-
01.13.21 -- New Year, New Podcast Episodes: Clinical Trials During A Pandemic; Gene Therapies At Scale
1/13/2021
01/13/21 Biosimilar Development Newsletter
-
01.07.21 -- Biosimilars In 2021 And Beyond
1/7/2021
01/07/21 Biosimilar Development Newsletter
-
12.22.20 -- Biosimilar Development Top 10 Of 2020
12/22/2020
12/22/20 Biosimilar Development Newsletter
-
12.18.20 -- Cytiva's Greatest Hits For Gene Therapy -- 2020 Edition
12/18/2020
12/18/20 Biosimilar Development Newsletter
-
12.17.20 -- 2020's Greatest Biosimilar Achievements
12/17/2020
12/17/20 Biosimilar Development Newsletter
-
12.11.20 -- Best Of 2020 - Process Development Efficiency And Outcomes
12/11/2020
12/11/20 Biosimilar Development Newsletter
-
12.10.20 -- Why Severability Should Be In Your Biosimilar Vocabulary
12/10/2020
12/10/20 Biosimilar Development Newsletter
-
12.08.20 -- New Podcast Episodes: 2021 Trends For Biotech, Modulation Of The Microbiome And Biopharma Financing
12/8/2020
12/08/20 Biosimilar Development Newsletter
-
12.03.20 -- 3 Perspectives On Biosimilars & Biobetter Development
12/3/2020
12/03/20 Biosimilar Development Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more